vs
Side-by-side financial comparison of Protalix BioTherapeutics, Inc. (PLX) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.
Protalix BioTherapeutics, Inc. is the larger business by last-quarter revenue ($9.1M vs $8.4M, roughly 1.1× Soluna Holdings, Inc). Protalix BioTherapeutics, Inc. runs the higher net margin — -60.3% vs -284.7%, a 224.3% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-6.8M). Over the past eight quarters, Protalix BioTherapeutics, Inc.'s revenue compounded faster (-6.7% CAGR vs -8.8%).
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
PLX vs SLNH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $8.4M |
| Net Profit | $-5.5M | $-24.0M |
| Gross Margin | 49.4% | 9.5% |
| Operating Margin | -51.1% | -92.5% |
| Net Margin | -60.3% | -284.7% |
| Revenue YoY | -49.9% | 11.8% |
| Net Profit YoY | -184.8% | -233.2% |
| EPS (diluted) | $-0.06 | $-1.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.1M | — | ||
| Q3 25 | $17.9M | $8.4M | ||
| Q2 25 | $15.7M | $6.2M | ||
| Q1 25 | $10.1M | $5.9M | ||
| Q4 24 | $18.2M | $8.3M | ||
| Q3 24 | $18.0M | $7.5M | ||
| Q2 24 | $13.5M | $9.7M | ||
| Q1 24 | — | $12.5M |
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $2.4M | $-24.0M | ||
| Q2 25 | $164.0K | $-7.4M | ||
| Q1 25 | $-3.6M | $-7.6M | ||
| Q4 24 | $6.5M | $-40.0M | ||
| Q3 24 | $3.2M | $-7.2M | ||
| Q2 24 | $-2.2M | $-10.9M | ||
| Q1 24 | — | $-5.3M |
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | 9.5% | ||
| Q2 25 | 62.5% | 6.3% | ||
| Q1 25 | 19.1% | 5.7% | ||
| Q4 24 | 78.7% | -360.8% | ||
| Q3 24 | 53.4% | -39.1% | ||
| Q2 24 | 29.8% | 34.6% | ||
| Q1 24 | — | 45.4% |
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | -92.5% | ||
| Q2 25 | 7.5% | -107.6% | ||
| Q1 25 | -41.0% | -120.9% | ||
| Q4 24 | 39.6% | -426.0% | ||
| Q3 24 | 22.2% | -119.8% | ||
| Q2 24 | -18.0% | -38.0% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | -60.3% | — | ||
| Q3 25 | 13.2% | -284.7% | ||
| Q2 25 | 1.0% | -119.9% | ||
| Q1 25 | -35.8% | -127.3% | ||
| Q4 24 | 35.6% | -483.8% | ||
| Q3 24 | 18.0% | -95.5% | ||
| Q2 24 | -16.4% | -112.4% | ||
| Q1 24 | — | -41.9% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | $-1.14 | ||
| Q2 25 | $0.00 | $-0.93 | ||
| Q1 25 | $-0.05 | $-1.21 | ||
| Q4 24 | $0.10 | $-7.14 | ||
| Q3 24 | $0.03 | $-1.56 | ||
| Q2 24 | $-0.03 | $-3.62 | ||
| Q1 24 | — | $-2.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.7M | — |
| Total DebtLower is stronger | — | $13.3M |
| Stockholders' EquityBook value | $48.2M | $14.5M |
| Total Assets | $82.3M | $152.0M |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $17.9M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.4M | — | ||
| Q2 24 | $23.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | — | $10.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $8.1M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | — |
| Q4 25 | $48.2M | — | ||
| Q3 25 | $52.9M | $14.5M | ||
| Q2 25 | $49.9M | $-19.5M | ||
| Q1 25 | $45.2M | $-16.1M | ||
| Q4 24 | $43.2M | $-12.5M | ||
| Q3 24 | $32.4M | $20.9M | ||
| Q2 24 | $28.6M | $24.4M | ||
| Q1 24 | — | $21.5M |
| Q4 25 | $82.3M | — | ||
| Q3 25 | $82.3M | $152.0M | ||
| Q2 25 | $78.5M | $92.0M | ||
| Q1 25 | $73.9M | $90.0M | ||
| Q4 24 | $73.4M | $88.0M | ||
| Q3 24 | $61.6M | $97.3M | ||
| Q2 24 | $91.5M | $98.7M | ||
| Q1 24 | — | $90.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $-2.2M |
| Free Cash FlowOCF − Capex | $1.6M | $-6.8M |
| FCF MarginFCF / Revenue | 17.8% | -81.4% |
| Capex IntensityCapex / Revenue | 4.4% | 55.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.6M | $-34.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-3.7M | $-2.2M | ||
| Q2 25 | $-5.2M | $-1.1M | ||
| Q1 25 | $-5.1M | $-177.0K | ||
| Q4 24 | $4.0M | $-5.1M | ||
| Q3 24 | $4.1M | $61.0K | ||
| Q2 24 | $-3.6M | $-7.3M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | $-6.8M | ||
| Q2 25 | $-5.7M | $-9.7M | ||
| Q1 25 | $-5.4M | $-4.0M | ||
| Q4 24 | $3.6M | $-13.9M | ||
| Q3 24 | $4.0M | $-3.4M | ||
| Q2 24 | $-3.8M | $-7.6M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | -81.4% | ||
| Q2 25 | -36.2% | -156.8% | ||
| Q1 25 | -53.0% | -67.1% | ||
| Q4 24 | 19.6% | -168.3% | ||
| Q3 24 | 22.4% | -44.8% | ||
| Q2 24 | -28.1% | -78.2% | ||
| Q1 24 | — | 26.5% |
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.8% | 55.2% | ||
| Q2 25 | 2.8% | 139.0% | ||
| Q1 25 | 3.0% | 64.2% | ||
| Q4 24 | 2.3% | 107.0% | ||
| Q3 24 | 0.5% | 45.6% | ||
| Q2 24 | 1.3% | 2.5% | ||
| Q1 24 | — | 4.2% |
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
SLNH
| Data Hosting Revenue | $5.3M | 62% |
| Cryptocurrency Mining Revenue | $2.8M | 33% |
| Other | $389.0K | 5% |
